RI
RTW Investments Portfolio holdings
AUM
$7.02B
This Quarter Return
+10.81%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$4.15B
AUM Growth
+$4.15B
(+17%)
Cap. Flow
+$521M
Cap. Flow
% of AUM
12.54%
Top 10 Holdings %
Top 10 Hldgs %
45.29%
Holding
99
New
22
Increased
37
Reduced
6
Closed
9
Top Buys
| 1 |
Immunovant
IMVT
|
$63.1M |
| 2 |
Illumina
ILMN
|
$54.1M |
| 3 |
Guardant Health
GH
|
$52.5M |
| 4 |
Athira Pharma
ATHA
|
$45.4M |
| 5 |
Cytokinetics
CYTK
|
$40.7M |
Top Sells
| 1 |
Wave Life Sciences
WVE
|
$24.9M |
| 2 |
Q32 Bio
QTTB
|
$19.6M |
| 3 |
STAAR Surgical
STAA
|
$19M |
| 4 |
NeoGenomics
NEO
|
$13.8M |
| 5 |
Repare Therapeutics
RPTX
|
$6.98M |
Sector Composition
| 1 | Healthcare | 92.6% |
| 2 | Materials | 0.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Arbutus Biopharma
ABUS
$753M
| $18.7M | 0.45% |
5,978,355
-890,926
| -13% | -$2.79M |
|
52
PMV Pharmaceuticals
PMVP
$82.1M
| $17.8M | 0.43% |
+500,000
| New | +$17.8M |
|
53
Altimmune
ALT
$325M
| $17.6M | 0.42% |
+1,334,940
| New | +$17.6M |
|
54
MiMedx Group
MDXG
$1.05B
| $17.2M | 0.41% |
2,700,320
| – | – |
|
55
Immunic
IMUX
$79.4M
| $16.9M | 0.41% |
+912,496
| New | +$16.9M |
|
56
Apyx Medical
APYX
$71.9M
| $16M | 0.38% |
3,391,279
| – | – |
|
|
AMRS
57
DELISTED
Amyris Inc.
AMRS
| $15.1M | 0.36% |
5,161,347
+2,057,812
| +66% | +$6.01M |
|
58
Exagen
XGN
$213M
| $13.6M | 0.33% |
1,250,131
-5,000
| -0.4% | -$54.2K |
|
|
AFIB
59
DELISTED
Acutus Medical, Inc. Common Stock
AFIB
| $13.5M | 0.32% |
+451,834
| New | +$13.5M |
|
|
ODT
60
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $13.4M | 0.32% |
999,256
+518,229
| +108% | +$6.96M |
|
|
GNMK
61
DELISTED
GenMark Diagnostics, Inc
GNMK
| $10.8M | 0.26% |
762,994
-172,212
| -18% | -$2.45M |
|
62
Arcturus Therapeutics
ARCT
$467M
| $10.8M | 0.26% |
+251,236
| New | +$10.8M |
|
63
CytomX Therapeutics
CTMX
$350M
| $10.1M | 0.24% |
1,526,003
+11,527
| +0.8% | +$76.7K |
|
|
LJPC
64
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $9.65M | 0.23% |
2,395,029
+20,077
| +0.8% | +$80.9K |
|
|
BLU
65
DELISTED
BELLUS Health Inc.
BLU
| $9.55M | 0.23% |
4,195,356
-1,774,874
| -30% | -$4.04M |
|
|
ITMR
66
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
| $9.34M | 0.22% |
457,218
| – | – |
|
67
Fulcrum Therapeutics
FULC
$353M
| $9.12M | 0.22% |
+1,150,565
| New | +$9.12M |
|
68
InMode
INMD
$917M
| $9.05M | 0.22% |
250,000
| – | – |
|
69
Regenxbio
RGNX
$498M
| $8.76M | 0.21% |
318,434
+2,406
| +0.8% | +$66.2K |
|
70
argenx
ARGX
$44.2B
| $8.34M | 0.2% |
31,752
| – | – |
|
|
PNT
71
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $7.05M | 0.17% |
+490,000
| New | +$7.05M |
|
72
Transmedics
TMDX
$3.65B
| $6.94M | 0.17% |
503,266
| – | – |
|
|
LSACU
73
DELISTED
LifeSci Acquisition Corp. Unit 1 COM & 1 WT
LSACU
| $6.8M | 0.16% |
500,000
| – | – |
|
|
BWAY
74
Brainsway
BWAY
$296M
| $6.46M | 0.16% |
1,107,420
| – | – |
|
75
Tango Therapeutics
TNGX
$745M
| $6.22M | 0.15% |
+600,000
| New | +$6.22M |
|